Ilana Jacqueline

(Editor) Ilana Jacqueline is the Managing Editor of The RARE Daily at Global Genes. She assists the patient community in getting their stories heard and shared so that they can connect, educate and inspire. Ms. Jacqueline has been reporting on health and other issues both online and in print for the last ten years. She has personal experience as a rare disease patient with Primary Immune Deficiency Disease and keeps a blog discussing her experiences at

In the past, Ms. Jacqueline has written for The Palm Beach PostThe Sun-SentinelThe Huffington PostCosmopolitanMarie Claire, Everyday HealthAOL, and her first book, Overcoming Chronic Illness (Demos Health) will hit shelves in August 2015.

Ilana Jacqueline is a South Florida native who has never seen snow, decorates about three months too early for the holidays and is torn over whether or not she wants to have children…or maybe just more poodles?

You can see more of her work at The Huffington Post, Cosmopolitan and, of course, on her blog Let’s Feel Better.

Want to reach out? You can email Ilana at

2017 RARE Patient Impact Grant Awardees
The RARE Patient Impact Grant Program offers support groups and nonprofits that care for patients affected by rare diseases the… Continue Reading
RARECast: Moving Rare Disease Therapies from Hope to Reality
World Rare Disease Day, an annual international effort to create awareness for rare diseases, will take place on February 28th. This year,… Continue Reading
NYC Health and Hospital Celebrates Rare Disease Day
NYC Health and Hospital are celebrating World Rare Disease Day this year with a day of events!   Did You Know?? 1 in 10 people has a rare… Continue Reading
The Quest for Unity On World Rare Disease Day: Disability Dudes Interview Multiple Organizations in New Podcast
In the rare disease community, strength is in unity and supporting one another. February 28th is globally recognized as Rare Disease Day.… Continue Reading
Cambridge BioMarketing Campaign Raises Awareness for Rare Disease Research
Cambridge BioMarketing, the world’s leading rare disease and specialty communications agency, announced its #SupportTheSearch social media… Continue Reading
Sanofi Genzyme’s Phase 2 Clinical Trial to Evaluate Oral Substrate Reduction Therapy for Gaucher Disease Type 3
Sanofi Genzyme is investigating an orally administered substrate reduction therapy in Gaucher disease type 3 as part of the 2-part LEAP… Continue Reading
RARECast: Children’s National Launches First-of-its-Kind Rare Disease Center
Last month, Children’s National Health System, the world’s largest provider of care for children with rare genetic disorders, announced… Continue Reading